300972.SHE Fujian Wanchen Biotechnology Co. Ltd
- Market cap
- CNY 28.2B
- P/E
- 12.2x
- P/B
- 8.49x
- ROE
- 73.8%
- Dividend yield
- 0.62%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300972.SHE undervalued?
Graham number300972.SHE trades 114.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Fujian Wanchen Biotechnology Co. Ltd fundamental analysis
No fundamental analysis for Fujian Wanchen Biotechnology Co. Ltd yet.
Fujian Wanchen Biotechnology Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Fujian Wanchen Biotechnology Co. Ltd
Fujian Wanchen Food Group Co., Ltd., together with its subsidiaries, engages in the research, development, cultivation, production, and sale of edible fungi in China and internationally. The company provides white and golden enoki, crab, white jade, deer antler, seafood, oyster, and other mushrooms products. It is also involved in breeding and fruit testing to produce new variants of edible fungi. The company sells its products through supermarket chains, restaurants, and on…
Full company profileFujian Wanchen Biotechnology Co. Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Fujian Wanchen Biotechnology Co. Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 451M | 450M | 435M | 549M | 9.29B | 32.3B | 51.5B | 74.2B |
| Gross Profit | 132M | 125M | 44.9M | 87.7M | 864M | 3.48B | 6.38B | 9.57B |
| Operating Income | 108M | 104M | 33.5M | 45.6M | -31.7M | 1.11B | 3.31B | 5.10B |
| EBITDA | 222M | 171M | 96.4M | 110M | 126M | 1.35B | 3.58B | 5.12B |
| Net Income | 92.2M | 96.1M | 23.4M | 47.7M | -82.9M | 294M | 1.34B | 2.45B |
| EPS | 0.80 | 0.84 | 0.15 | 0.31 | -0.54 | 1.63 | 7.12 | 12 |
| Balance Sheet | ||||||||
| Total Assets | 656M | 659M | 863M | 1.20B | 3.93B | 7.25B | 10.0B | 13.4B |
| Total Liabilities | 311M | 258M | 210M | 529M | 3.23B | 5.79B | 7.50B | 8.09B |
| Shareholders' Equity | 345M | 401M | 653M | 668M | 645M | 1.10B | 1.48B | 3.32B |
| Cash & Short-term Investments | 27.2M | 33.5M | 216M | 115M | 1.21B | 2.38B | 4.74B | 6.07B |
| Cash Flow | ||||||||
| Operating Cash Flow | 177M | 156M | 98.8M | 70.4M | 1.02B | 848M | 3.63B | - |
| Capital Expenditure | 39.7M | 56.1M | 41.6M | 316M | 219M | 117M | 77.4M | 94.4M |
| Free Cash Flow | 138M | 100M | 57.3M | -246M | 804M | 732M | 3.55B | 3.05B |
| Ratios | ||||||||
| ROE | 26.7% | 24.0% | 3.6% | 7.1% | -12.8% | 26.7% | 90.7% | 73.8% |
| ROA | 14.1% | 14.6% | 2.7% | 4.0% | -2.1% | 4.0% | 13.4% | 18.3% |
| Net Profit Margin | 20.4% | 21.4% | 5.4% | 8.7% | -0.9% | 0.9% | 2.6% | 3.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Fujian Wanchen Biotechnology Co. Ltd dividends
- Dividend yield
- 0.62%
- Forward dividend
- 1.14 CNY
- Payout ratio
- 13.1%
- Ex-dividend date
- Sep 24, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 176M | 0.93 | 13.1% |
| 2024 | CNY 30.0M | 0.17 | 10.2% |
| 2023 | CNY 15.2M | 0.10 | - |
| 2022 | CNY 39.2M | 0.26 | 82.2% |
| 2021 | CNY 5.23M | 0.03 | 22.3% |
| 2020 | CNY 49.0M | 0.43 | 51.0% |
| 2019 | CNY 94.7M | 0.82 | 102.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Fujian Wanchen Biotechnology Co. Ltd
- Insiders 61.15%
- Institutions 8.98%
- Public & others 29.87%
- Shares outstanding 199M
- Free float 96.0M
Fujian Wanchen Biotechnology Co. Ltd company profile
- Company name
- Fujian Wanchen Biotechnology Co. Ltd
- Ticker
- 300972.SHE
- ISIN
- CNE100004KH1
- Exchange
- Shenzhen Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 9,073
- Fiscal year end
- December
- Address
- Fujian Zhangpu Taiwan Farmers' Entrepren, Zhangpu, China, 363204
- Phone
- 86 59 6631 2889
- Website
- vanchen.com
About Fujian Wanchen Biotechnology Co. Ltd
Fujian Wanchen Food Group Co., Ltd., together with its subsidiaries, engages in the research, development, cultivation, production, and sale of edible fungi in China and internationally. The company provides white and golden enoki, crab, white jade, deer antler, seafood, oyster, and other mushrooms products. It is also involved in breeding and fruit testing to produce new variants of edible fungi. The company sells its products through supermarket chains, restaurants, and online food platforms. It exports its products. The company was formerly known as Fujian Wanchen Biotechnology Group Co.,Ltd. and changed its name to Fujian Wanchen Food Group Co., Ltd. in January 2026. Fujian Wanchen Food Group Co., Ltd. was founded in 2011 and is headquartered in Zhangpu, China.
Fujian Wanchen Biotechnology Co. Ltd management
7- Mr. Zening WangGM & Director · born 1993
- Ms. Dong Na CaiDeputy GM, CFO & Secretary of the Board · born 1971
- Mr. Bo LiDeputy GM & Employee Representative Director · born 1983
- Mr. Song WangDeputy General Manager · born 1986
- Mr. Jun YangDeputy General Manager · born 1985
- Arong HuangAccounting Supervisor
- Makoto HasegawaGeneral Manager of Broadband & Network Business Division